Fetal heart rate changes on the cardiotocograph trace secondary to maternal COVID-19 infection.


Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 28 04 2020
accepted: 25 06 2020
pubmed: 10 7 2020
medline: 12 9 2020
entrez: 10 7 2020
Statut: ppublish

Résumé

To determine the cardiotocograph (CTG) changes in women with symptomatic COVID-19 infection. 12 anonymised CTG traces from 2 hospitals in Spain were retrospectively analysed by 2 independent assessors. CTG parameters were studied based on fetal pathophysiological responses to inflammation and hypoxia that would be expected based on the pathogenesis of COVID-19 patients. Correlation was made with perinatal outcomes (Apgar score at 5 min and umbilical cord pH). All fetuses showed an increased baseline FHR > 10 percent compared to the initial recording, in addition to absence of accelerations. 10 out of 12 CTG traces (83.3 percent) demonstrated late or prolonged decelerations and 7 out of 12 fetuses (58.3 percent) showed absence of cycling. Not a single case of sinusoidal pattern was observed. ZigZag pattern was found in 4 CTG traces (33 percent). Excessive uterine activity was observed in all CTG traces where uterine activity was monitored (10 out of 12). Apgar scores at 5 min were normal (>7) and absence of metabolic acidosis was found in the umbilical cord arterial pH (pH > 7.0) in the cases that were available (11 and 9, respectively). Fetuses of COVID-19 patients showed a raised baseline FHR (>10 percent), loss of accelerations, late decelerations, ZigZag pattern and absence of cycling probably due to the effects of maternal pyrexia, maternal inflammatory response and the "cytokine storm". However, the perinatal outcomes appear to be favourable. Therefore, healthcare providers should optimise the maternal environment first to rectify the reactive CTG changes instead of performing an urgent operative intervention.

Identifiants

pubmed: 32645644
pii: S0301-2115(20)30424-3
doi: 10.1016/j.ejogrb.2020.06.049
pmc: PMC7331544
pii:
doi:

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

286-293

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Best Pract Res Clin Obstet Gynaecol. 2007 Aug;21(4):609-24
pubmed: 17400026
J Pharm Anal. 2020 Apr;10(2):102-108
pubmed: 32282863
Ann Intern Med. 2020 Sep 1;173(5):402-404
pubmed: 32282871
Eur Respir J. 2020 Apr 16;55(4):
pubmed: 32269085
Am J Perinatol. 2020 Jun;37(8):861-865
pubmed: 32305046
Travel Med Infect Dis. 2020 Apr 11;:101665
pubmed: 32283217
Am J Obstet Gynecol. 2020 May;222(5):415-426
pubmed: 32105680
J Matern Fetal Neonatal Med. 2021 Nov;34(21):3537-3545
pubmed: 31722586
Am J Hematol. 2020 Jul;95(7):834-847
pubmed: 32282949
Lancet. 2020 Mar 7;395(10226):809-815
pubmed: 32151335
Best Pract Res Clin Obstet Gynaecol. 2016 Jan;30:33-47
pubmed: 26165747

Auteurs

Anna Gracia-Perez-Bonfils (A)

Hospital General de l'Hospitalet, Barcelona, Spain; Autonomous University of Barcelona, Spain. Electronic address: gracia.anna@gmail.com.

Oscar Martinez-Perez (O)

Obs Simulation Unit, Spain; Puerta de Hierro-Majadahonda University Hospital, Universidad Autónoma de Madrid, Spain; Universidad Católica de Murcia, Spain.

Elisa Llurba (E)

Sant Pau University Hospital, Barcelona, Spain.

Edwin Chandraharan (E)

Global Academy of Medical Education & Training, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH